Institutional investors purchased a net $1.4 million shares of IMMU during the quarter ended March 2015 and now own 44.13% of the total shares outstanding. This is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
STATE OF WISCONSIN INVESTMENT BO... Bought 1.5 Million shares of Immunomedics Inc
TEKLA CAPITAL MANAGEMENT LLC Bought 500.0 Thousand shares of Immunomedics Inc
BELLEVUE ASSET MANAGEMENT AG Bought 400.0 Thousand shares of Immunomedics Inc